Table 1 Demographic and clinical characteristics of patients in LA LSPDP and CA LSPDP groups.

From: Efficacy and safety of lateral approach laparoscopic spleen-preserving distal pancreatectomy: a multicenter retrospective cohort study

Characteristics

Before propensity score matching

After propensity score matching

LA LSPDP

(N = 56)

CA LSPDP

(N = 116)

p value

LA LSPDP

(N = 56)

CA LSPDP

(N = 56)

p value

Age, yrs

51.9 ± 18.19

59.7 ± 15.91

0.004

51.9 ± 18.19

53.8 ± 17.72

0.575

Sex, N (%)

  

0.611

  

0.43

 Male

18 (32.1)

43 (37.1)

 

18 (32.1)

22 (39.3)

 

 Female

38 (67.9)

73 (62.9)

 

38 (67.9)

34 (60.7)

 

BMI, kg/m2

25 ± 4.04

24.8 ± 3.33

0.721

25 ± 4.04

25.1 ± 3.38

0.966

Charlson Comorbidity index

1.5 ± 1.66

2.4 ± 1.84

0.005

1.5 ± 1.66

1.8 ± 1.66

0.461

ASA score, N (%)

  

0.011

  

0.324

 1

18 (32.1)

19 (16.4)

 

18 (32.1)

13 (23.2)

 

 2

37 (66.1)

90 (77.6)

 

37 (66.1)

42 (75)

 

 3

1 (1.8)

7 (6)

 

1 (1.8)

1 (1.8)

 

Comorbidity, N (%)

      

 Hypertension

16 (28.6)

51 (44)

0.052

16 (28.6)

20 (35.7)

0.418

 Diabetes mellitus

8 (14.3)

33 (28.4)

0.041

8 (14.3)

13 (23.2)

0.226

 Cardiac disease

5 (8.9)

13 (11.2)

0.647

5 (8.9)

4 (7.1)

1.000

 COPD

0

3 (2.6)

0.552

0

0

 

 Previous history of operation

17 (30.4)

31 (26.7)

0.619

17 (30.4)

12 (41.4)

0.281

Pathologys, N (%)

  

0.393

  

1.000

 IPMN

8 (14.3)

38 (32.8)

 

8 (14.3)

11 (19.6)

 

 NET

15 (26.8)

14 (12.1)

 

15 (26.8)

9 (16.1)

 

 SPN

10 (17.9)

6 (5.2)

 

10 (17.9)

4 (7.1)

 

 SCN

7 (12.5)

21 (18.1)

 

7 (12.5)

13 (23.2)

 

 MCN

2 (3.6)

15 (12.9)

 

2 (3.6)

9 (16.1)

 

 Pancreatitis

0

6 (5.2)

 

0

1 (1.8)

 

 Pseudocyst

3 (5.4)

3 (2.6)

 

3 (5.4)

2 (3.6)

 

 Others

11 (19.6)

13 (11.2)

 

11 (19.6)

7 (12.5)

 

Tumor location, cm*

4.3 ± 1.34

5 ± 1.27

0.078

4.3 ± 1.34

4.8 ± 1.22

0.252

Tumor size, cm

3.1 ± 1.95

3.5 ± 2.14

0.233

3.1 ± 1.95

3.3 ± 2.16

0.549

Specimen length, cm

7.7 ± 1.69

9.4 ± 2.55

 < 0.001

7.7 ± 1.69

8.4 ± 2.45

 < 0.001

  1. LA LSPDP lateral approach laparoscopic spleen-preserving distal pancreatectomy; CA LSPDP conventional approach to laparoscopic spleen-preserving distal pancreatectomy; BMI body mass index; ASA American Society of Anesthesiologists; COPD chronic obstructive pulmonary disease; IPMN intraductal papillary mucinous neoplasm; NET neuroendocrine tumor; SPN solid pseudopapillary neoplasm; SCN serous cystic neoplasm; MCN mucinous cyst neoplasm.
  2. *Tumor location was defined as the distance from the lateral border of the aorta to the center of the tumor.
Back to article page